CDSCO-2022-0093-V493
Type IB variation for application CDSCO-2022-0093. Type IB variation: Specification Change for Tiotropizone — critical change
Variation Number
CDSCO-2022-0093-V493
Type
Type IB
Application
Change
Status
Submitted
Fee
€961
Submitted
—
Approved
—
Description
Type IB variation: Specification Change for Tiotropizone — critical change